- Home
- NAC vs CERT Comparison
NAC vs CERT Comparison
Compare NAC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAC
- CERT
- Stock Information
- Founded
- NAC 1998
- CERT 2008
- Country
- NAC France
- CERT United States
- Employees
- NAC N/A
- CERT N/A
- Industry
- NAC Investment Managers
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- NAC Finance
- CERT Technology
- Exchange
- NAC Nasdaq
- CERT Nasdaq
- Market Cap
- NAC 1.6B
- CERT 1.7B
- IPO Year
- NAC N/A
- CERT 2020
- Fundamental
- Price
- NAC $11.16
- CERT $11.70
- Analyst Decision
- NAC
- CERT Buy
- Analyst Count
- NAC 0
- CERT 6
- Target Price
- NAC N/A
- CERT $15.60
- AVG Volume (30 Days)
- NAC 307.3K
- CERT 2.0M
- Earning Date
- NAC 01-01-0001
- CERT 08-05-2025
- Dividend Yield
- NAC 4.33%
- CERT N/A
- EPS Growth
- NAC N/A
- CERT N/A
- EPS
- NAC N/A
- CERT N/A
- Revenue
- NAC N/A
- CERT $394,498,000.00
- Revenue This Year
- NAC N/A
- CERT $11.57
- Revenue Next Year
- NAC N/A
- CERT $8.93
- P/E Ratio
- NAC N/A
- CERT N/A
- Revenue Growth
- NAC N/A
- CERT 9.37
- 52 Week Low
- NAC $9.32
- CERT $8.64
- 52 Week High
- NAC $11.21
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- NAC 63.17
- CERT 55.84
- Support Level
- NAC $10.98
- CERT $10.23
- Resistance Level
- NAC $11.11
- CERT $12.41
- Average True Range (ATR)
- NAC 0.07
- CERT 0.50
- MACD
- NAC 0.02
- CERT 0.09
- Stochastic Oscillator
- NAC 96.12
- CERT 67.40
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.